• ALESSI, D.R., CUENDA, A., COHEN, P., DUDLEY, D.T. & SALTIEL, A.R. (1995). PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem., 270, 2748927494.
  • BARBIER, A.J., POPPLETON, H.M., YIGZAW, Y., MULLENIX, J.B., WIEPZ, G.J., BERTICS, P.J. & PATEL, T.B. (1999). Transmodulation of epidermal growth factor receptor function by cyclic AMP-dependent protein kinase. J. Biol. Chem., 274, 1406714073.
  • CHOI, D.Y., TOLEDO-ARAL, J.J., SEGAL, R. & HALEGOUA, S. (2001). Sustained signaling by phospholipase C-gamma mediates nerve growth factor-triggered gene expression. Mol. Cell. Biol., 21, 26952705.
  • COSTANTINI, L.C., COLE, D., CHATURVEDI, P. & ISACSON, O. (2001). Immunophilin ligands can prevent progressive dopaminergic degeneration in animal models of Parkinson's disease. Eur. J. Neurosci., 13, 10851092.
  • FAVATA, M.F., HORIUCHI, K.Y., MANOS, E.J., DAULERIO, A.J., STRADLEY, D.A., FEESER, W.S., VAN DYK, D.E., PITTS, W.J., EARL, R.A., HOBBS, F., COPELAND, R.A., MAGOLDA, R.L., SCHERLE, P.A. & TRZASKOS, J.M. (1998). Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem., 273, 1862318632.
  • GOLD, B.G. (2000). Neuroimmunophilin ligands: evaluation of their therapeutic potential for the treatment of neurological disorders. Expert Opin. Investig. Drugs, 9, 23312342.
  • GOLD, B.G., DENSMORE, V., SHOU, W., MATZUK, M.M. & GORDON, H.S. (1999a). Immunophilin FK506-binding protein 52 (not FK506-binding protein 12) mediates the neurotrophic action of FK506. J. Pharmacol. Exp. Ther., 289, 12021210.
  • GOLD, B.G., GORDON, H.S. & WANG, M.-S. (1999b). Efficacy of delayed or discontinuous FK506 administrations on nerve regeneration in the rat sciatic nerve crush model: lack of evidence for a conditioning lesion-like effect. Neurosci. Lett., 267, 3336.
  • GOLD, B.G., ZELENY-POOLEY, M., WANG, M.S., CHATURVEDI, P. & ARMISTEAD, D.M. (1997). A nonimmunosuppressant FKBP-12 ligand increases nerve regeneration. Exp. Neurol., 147, 269278.
  • GUO, X., DAWSON, V.L. & DAWSON, T.M. (2001a). Neuroimmunophilin ligands exert neuroregeneration and neuroprotection in midbrain dopaminergic neurons. Eur. J. Neurosci., 13, 16831693.
  • GUO, X., DILLMAN III, J.F., DAWSON, V.L. & DAWSON, T.M. (2001b). Neuroimmunophilins: novel neuroprotective and neuroregenerative targets. Ann. Neurol., 50, 616.
  • HUANG, E.J. & REICHARDT, L.F. (2001). Neurotrophins: roles in neuronal development and function. Annu. Rev. Neurosci., 24, 677736.
  • JUNN, E. & MOURADIAN, M.M. (2001). Apoptotic signaling in dopamine-induced cell death: the role of oxidative stress, p38 mitogen-activated protein kinase, cytochrome c and caspases. J. Neurochem., 78, 374383.
  • KLETTNER, A., BAUMGRASS, R., ZHANG, Y., FISCHER, G., BURGER, E., HERDEGEN, T. & MIELKE, K. (2001). The neuroprotective actions of FK506 binding protein ligands: neuronal survival is triggered by de novo RNA synthesis, but is independent of inhibition of JNK and calcineurin. Brain Res. Mol. Brain Res., 97, 2131.
  • KLETTNER, A. & HERDEGEN, T. (2003). The immunophilin-ligands FK506 and V-10,367 mediate neuroprotection by the heat shock response. Br. J. Pharmacol., 138, 10041012.
  • KOBAYASHI, M., NAGATA, S., KITA, Y., NAKATSU, N., IHARA, S., KAIBUCHI, K., KURODA, S., UI, M., IBA, H., KONISHI, H., KIKKAWA, U., SAITOH, I. & FUKUI, Y. (1997). Expression of a constitutively active phosphatidylinositol 3-kinase induces process formation in rat PC12 cells Use of Cre/loxP recombination system. J. Biol. Chem., 272, 1608916092.
  • LACKEY, K., CORY, M., DAVIS, R., FRYE, S.V., HARRIS, P.A., HUNTER, R.N., JUNG, D.K., MCDONALD, O.B., MCNUTT, R.W., PEEL, M.R., RUTKOWSKE, R.D., VEAL, J.M. & WOOD, E.R. (2000). The discovery of potent cRafl kinase inhibitors. Bioorg. Med. Chem. Lett., 10, 223226.
  • MIELKE, K. & HERDEGEN, T. (2000). JNK and p38 stresskinases – degenerative effectors of signal-transduction-cascades in the nervous system. Prog. Neurobiol., 61, 4560.
  • MURAKAMI, Y., FURUKAWA, S., NITTA, A. & FURUKAWA, Y. (2002). Accumulation of nerve growth factor protein at both rostral and caudal stumps in the transected rat spinal cord. J. Neurol. Sci., 198, 6369.
  • OLSSON, A.K., VADHAMMAR, K. & NANBERG, E. (2000). Activation and protein kinase C-dependent nuclear accumulation of ERK in differentiating human neuroblastoma cells. Exp. Cell. Res., 256, 454467.
  • PURSIHEIMO, J.P., KIEKSI, A., JALKANEN, M. & SALMIVIRTA, M. (2002). Protein kinase A balances the growth factor-induced Ras/ERK signaling. FEBS Lett., 521, 157164.
  • SOFRONIEW, M.V., HOWE, C.L. & MOBLEY, W.C. (2001). Nerve growth factor signaling, neuroprotection, and neural repair. Annu. Rev. Neurosci., 24, 12171281.
  • STEINER, J.P., HAMILTON, G.S., ROSS, D.T., VALENTINE, H.L., GUO, H., CONNOLLY, M.A., LIANG, S., RAMSEY, C., LI, J.H., HUANG, W., HOWORTH, P., SONI, R., FULLER, M., SAUER, H., NOWOTNIK, A.C. & SUZDAK, P.D. (1997). Neurotrophic immunophilin ligands stimulate structural and functional recovery in neurodegenerative animal models. Proc. Natl. Acad. Sci. U.S.A., 94, 20192024.
  • SULAIMAN, O.A., VODA, J., GOLD, B.G. & GORDON, T. (2002). FK506 increases peripheral nerve regeneration after chronic axotomy but not after chronic Schwann cell denervation. Exp. Neurol., 175, 127137.
  • TANAKA, K., FUJITA, N., HIGASHI, Y. & OGAWA, N. (2002). Neuroprotective and antioxidant properties of FKBP-binding immunophilin ligands are independent on the FKBP12 pathway in human cells. Neurosci. Lett., 330, 147150.
  • UTSUGI, M., DOBASHI, K., ISHIZUKA, T., ENDOU, K., HAMURO, J., MURATA, Y., NAKAZAWA, T. & MORI, M. (2003). c-Jun N-terminal kinase negatively regulates lipopolysaccharide-induced IL-12 production in human macrophages: role of mitogen-activated protein kinase in glutathione redox regulation of IL-12 production. J. Immunol., 171, 628635.